BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns
Go back to BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns| ALKERMES (NASDAQ: ALKS) | Delayed: 45.49 -0.61 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.10 | 52 Week High | $80.71 | |||
| Open | $45.20 | 52 Week Low | $27.14 | |||
| Day High | $46.53 | P/E | 349.92 | |||
| Day Low | $44.63 | EPS | $0.13 | |||
| Volume | 1,355,833 | |||||
| AMER PHYSICIANS (NASDAQ: AMPH) | Delayed: 22.93 -0.25 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.18 | 52 Week High | $21.53 | |||
| Open | $22.82 | 52 Week Low | $10.50 | |||
| Day High | $23.14 | P/E | 7.01 | |||
| Day Low | $22.30 | EPS | $3.27 | |||
| Volume | 460,015 | |||||
| (NYSE: BHVN) | Delayed: 14.72 -0.97 (6.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.69 | 52 Week High | $ | |||
| Open | $14.91 | 52 Week Low | $ | |||
| Day High | $15.80 | P/E | N/A | |||
| Day Low | $14.33 | EPS | $ | |||
| Volume | 3,306,272 | |||||
